The “No profit on the pandemic” campaign is spreading an important message throughout Europe: the intellectual property of pharmaceutical companies is a barrier in the way of halting Covid’s spread. Unfortunately, the reasoning is at the very least incomplete and the means unproductive. But it is worth a discussion.
We are publishing some of the questions raised by readers following the communiqué we released yesterday.
An assessment of the historical moment we are facing, the lessons of the pandemic and the outlook for what lies ahead, so that we can begin to respond appropriately to what the situation demands from us.
The new variants of Covid threaten new, even greater, waves of infection and put the vaccine in check. They are the direct product of the inability of the ruling class to give universal answers to universal problems.
EU politicians are right about one thing: delaying vaccination hurts capital and its businesses and above all -even if they try to render it invisible- it costs the lives of workers and the general population. If, as they point out and appears likely, this delay is partly due to a narrow choice of main supplier to create a biotechnological champion, the EU would have shown to what extent the peaceful and civilized European project is capable of the worst crimes to serve the interests of German capital.
The increase in hospitalizations, the ongoing strikes and the failure of the Oxford vaccine are not isolated events. What is coming next? An increasingly clear increase in all of these contradictions, with states and media trying to push back the reality of the pandemic and its consequences and making workers’ struggles even more brazenly invisible. And on the horizon, the pressing need for self-centralization and extension of the struggles.